SMTL ID : 5u4c.1

Wild-type Transthyretin in complex with 3-[(1E)-2-(4-Boronic acid)ethenyl]benzoic Acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

homo-tetramer

Ligands

4 x XBS: 3-[(E)-2-(4-boronophenyl)ethenyl]benzoic acid(Non-covalent)

XBS.1: 10 residues within 4Å: Chain A: K.16, L.18, A.109, L.111, S.118 Chain C: K.16, E.55, A.109, S.118 Ligands: XBS.3 10 PLIP interactions: 5 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:K.16, C:A.109, A:L.18, A:A.109, A:L.111 Hydrogen bonds: C:K.16, C:K.16, C:S.118, A:K.16, A:S.118 XBS.2: 13 residues within 4Å: Chain B: M.14, K.16, L.18, A.109, L.111, S.118 Chain D: K.16, L.18, A.109, L.111, S.118, T.120 Ligands: XBS.4 12 PLIP interactions: 6 interactions with chain D, 6 interactions with chain B Hydrophobic interactions: D:K.16, D:L.18, D:A.109, D:T.120, B:L.18, B:A.109, B:L.111 Hydrogen bonds: D:K.16, D:S.118, B:K.16, B:K.16, B:S.118 XBS.3: 10 residues within 4Å: Chain A: K.16, E.55, A.109, S.118 Chain C: K.16, L.18, A.109, L.111, S.118 Ligands: XBS.1 10 PLIP interactions: 5 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:L.18, C:A.109, C:L.111, A:K.16, A:A.109 Hydrogen bonds: C:K.16, C:S.118, A:K.16, A:K.16, A:S.118 XBS.4: 13 residues within 4Å: Chain B: K.16, L.18, A.109, L.111, S.118, T.120 Chain D: M.14, K.16, L.18, A.109, L.111, S.118 Ligands: XBS.2 12 PLIP interactions: 6 interactions with chain D, 6 interactions with chain B Hydrophobic interactions: D:L.18, D:A.109, D:L.111, B:K.16, B:L.18, B:A.109, B:T.120 Hydrogen bonds: D:K.16, D:K.16, D:S.118, B:K.16, B:S.118

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Smith, T.P. et al., Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation. J. Med. Chem. (2017)

Release Date

2017-09-27

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence